Published in Tissue Eng on December 01, 2006
In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials (2008) 3.39
Biodegradation of silk biomaterials. Int J Mol Sci (2009) 1.55
Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr Stem Cell Res Ther (2008) 1.53
Biomimetic approach to tissue engineering. Semin Cell Dev Biol (2008) 1.30
Vascularized bone tissue engineering: approaches for potential improvement. Tissue Eng Part B Rev (2012) 1.24
Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine. Semin Cell Dev Biol (2009) 1.21
Biomedical applications of chemically-modified silk fibroin. J Mater Chem (2009) 1.17
Stem cell bioprocessing: fundamentals and principles. J R Soc Interface (2009) 1.17
Microporous nanofibrous fibrin-based scaffolds for bone tissue engineering. Biomaterials (2008) 1.14
Relationships between degradability of silk scaffolds and osteogenesis. Biomaterials (2010) 1.11
Stereolithographic bone scaffold design parameters: osteogenic differentiation and signal expression. Tissue Eng Part B Rev (2010) 1.03
Geometry and force control of cell function. J Cell Biochem (2009) 0.98
The use of mesenchymal stem cells in tissue engineering: A global assessment. Organogenesis (2008) 0.91
Effect of scaffold microarchitecture on osteogenic differentiation of human mesenchymal stem cells. Eur Cell Mater (2013) 0.89
Hypoxia and amino acid supplementation synergistically promote the osteogenesis of human mesenchymal stem cells on silk protein scaffolds. Tissue Eng Part A (2010) 0.87
Remodeling of tissue-engineered bone structures in vivo. Eur J Pharm Biopharm (2013) 0.87
Novel porous scaffolds of poly(lactic acid) produced by phase-separation using room temperature ionic liquid and the assessments of biocompatibility. J Mater Sci Mater Med (2012) 0.86
Controlled Positioning of Cells in Biomaterials-Approaches Towards 3D Tissue Printing. J Funct Biomater (2011) 0.85
Silk constructs for delivery of musculoskeletal therapeutics. Adv Drug Deliv Rev (2012) 0.84
Aligned silk-based 3-D architectures for contact guidance in tissue engineering. Acta Biomater (2011) 0.81
Engineering stem cell niches in bioreactors. World J Stem Cells (2013) 0.81
Comparable efficacy of silk fibroin with the collagen membranes for guided bone regeneration in rat calvarial defects. J Adv Prosthodont (2014) 0.80
Hair follicle regeneration in skin grafts: current concepts and future perspectives. Tissue Eng Part B Rev (2011) 0.80
Transdermal delivery devices: fabrication, mechanics and drug release from silk. Small (2013) 0.78
Patterned silk film scaffolds for aligned lamellar bone tissue engineering. Macromol Biosci (2012) 0.77
Influence of silk-silica fusion protein design on silica condensation in vitro and cellular calcification. RSC Adv (2016) 0.77
MR Imaging of Stem Cell Transplants in Arthritic Joints. J Stem Cell Res Ther (2014) 0.75
Silk fibroin scaffolds with inverse opal structure for bone tissue engineering. J Biomed Mater Res B Appl Biomater (2016) 0.75
Engineering stem cells for treatment of osteochondral defects. Skeletal Radiol (2012) 0.75
Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res (2010) 9.95
Silk-based biomaterials. Biomaterials (2003) 7.72
Mechanism of silk processing in insects and spiders. Nature (2003) 4.85
Dissolvable films of silk fibroin for ultrathin conformal bio-integrated electronics. Nat Mater (2010) 4.62
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13
Silk as a Biomaterial. Prog Polym Sci (2007) 4.13
New opportunities for an ancient material. Science (2010) 3.95
Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials (2005) 3.87
Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol (2003) 3.71
In vitro degradation of silk fibroin. Biomaterials (2005) 3.56
Materials fabrication from Bombyx mori silk fibroin. Nat Protoc (2011) 3.45
In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials (2008) 3.39
Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials (2006) 3.27
Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A (2007) 3.19
Villification: how the gut gets its villi. Science (2013) 2.94
Stem cell-based tissue engineering with silk biomaterials. Biomaterials (2006) 2.88
The inflammatory responses to silk films in vitro and in vivo. Biomaterials (2005) 2.79
Porous 3-D scaffolds from regenerated silk fibroin. Biomacromolecules (2004) 2.77
Cell differentiation by mechanical stress. FASEB J (2001) 2.56
Engineering complex tissues. Tissue Eng (2006) 2.53
Structure and properties of silk hydrogels. Biomacromolecules (2004) 2.50
Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A (2009) 2.48
A physically transient form of silicon electronics. Science (2012) 2.47
Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol (2003) 2.42
Engineering anatomically shaped human bone grafts. Proc Natl Acad Sci U S A (2009) 2.37
Clinical correlates in an experimental model of repetitive mild brain injury. Ann Neurol (2013) 2.32
Vascularization strategies for tissue engineering. Tissue Eng Part B Rev (2009) 2.31
Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng (2004) 2.26
Regulation of silk material structure by temperature-controlled water vapor annealing. Biomacromolecules (2011) 2.24
Silk matrix for tissue engineered anterior cruciate ligaments. Biomaterials (2002) 2.22
Silk implants for the healing of critical size bone defects. Bone (2005) 2.22
Electrospinning Bombyx mori silk with poly(ethylene oxide). Biomacromolecules (2002) 2.20
Waterproof AlInGaP optoelectronics on stretchable substrates with applications in biomedicine and robotics. Nat Mater (2010) 2.20
Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng (2006) 2.20
Sonication-induced gelation of silk fibroin for cell encapsulation. Biomaterials (2007) 2.15
Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc Natl Acad Sci U S A (2011) 2.14
Quantitative evaluation of mechanical properties in tissue-engineered auricular cartilage. Tissue Eng Part B Rev (2013) 2.14
Engineering adipose-like tissue in vitro and in vivo utilizing human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D scaffolds. Biomaterials (2007) 2.13
Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res (2007) 2.12
Contribution of in vivo structural measurements and load/strength ratios to the determination of forearm fracture risk in postmenopausal women. J Bone Miner Res (2007) 2.11
Macrophage responses to silk. Biomaterials (2003) 2.04
In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials (2005) 2.02
Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng (2006) 2.01
Electrical stimulation systems for cardiac tissue engineering. Nat Protoc (2009) 1.97
Influence of macroporous protein scaffolds on bone tissue engineering from bone marrow stem cells. Biomaterials (2005) 1.94
Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A (2004) 1.94
Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. J Clin Endocrinol Metab (2013) 1.88
Water-insoluble silk films with silk I structure. Acta Biomater (2009) 1.85
Silk microspheres for encapsulation and controlled release. J Control Release (2006) 1.81
Bioactive silk protein biomaterial systems for optical devices. Biomacromolecules (2008) 1.79
High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol Bioeng (2003) 1.77
Decellularization of human and porcine lung tissues for pulmonary tissue engineering. Ann Thorac Surg (2013) 1.76
Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res (2011) 1.76
Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci Transl Med (2011) 1.74
Bone structure at the distal radius during adolescent growth. J Bone Miner Res (2009) 1.74
Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release (2008) 1.72
Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials (2007) 1.72
Silk fibroin as an organic polymer for controlled drug delivery. J Control Release (2006) 1.71
Assembly of complex cell microenvironments using geometrically docked hydrogel shapes. Proc Natl Acad Sci U S A (2013) 1.70
Effects of initial seeding density and fluid perfusion rate on formation of tissue-engineered bone. Tissue Eng Part A (2008) 1.70
Biomaterial films of Bombyx mori silk fibroin with poly(ethylene oxide). Biomacromolecules (2004) 1.70
Ultra-sensitive vibrational spectroscopy of protein monolayers with plasmonic nanoantenna arrays. Proc Natl Acad Sci U S A (2009) 1.69
Quantity and quality of trabecular bone in the femur are enhanced by a strongly anabolic, noninvasive mechanical intervention. J Bone Miner Res (2002) 1.68
Twenty-one millisecond pulsars in Terzan 5 using the Green Bank Telescope. Science (2005) 1.68
Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A (2006) 1.68
Human bone marrow stromal cell responses on electrospun silk fibroin mats. Biomaterials (2004) 1.67
Cartilage tissue engineering with silk scaffolds and human articular chondrocytes. Biomaterials (2006) 1.67
Role of membrane potential in the regulation of cell proliferation and differentiation. Stem Cell Rev (2009) 1.66
Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol (2004) 1.65
Cardiac tissue engineering using perfusion bioreactor systems. Nat Protoc (2008) 1.65
Dentin sialoprotein and dentin phosphoprotein have distinct roles in dentin mineralization. Matrix Biol (2009) 1.64
Engineering cartilage-like tissue using human mesenchymal stem cells and silk protein scaffolds. Biotechnol Bioeng (2004) 1.64
Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. J Biomed Mater Res A (2008) 1.63
Silk fibroin microtubes for blood vessel engineering. Biomaterials (2007) 1.61
Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. Cancer Res (2010) 1.61
Silk nanospheres and microspheres from silk/pva blend films for drug delivery. Biomaterials (2009) 1.59
Modification of silk fibroin using diazonium coupling chemistry and the effects on hMSC proliferation and differentiation. Biomaterials (2008) 1.59
Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A (2004) 1.59
Silk film biomaterials for cornea tissue engineering. Biomaterials (2008) 1.58
Silk polymer-based adenosine release: therapeutic potential for epilepsy. Biomaterials (2008) 1.57
Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials (2006) 1.56